Skip to main content
Clinical Trials/NL-OMON48407
NL-OMON48407
Withdrawn
Not Applicable

ano-MRI to visualize pancreatic inflammation in individuals with recent-onset type 1 diabetes - Nano-PRIDE

ucleaire geneeskunde en radiologie0 sites25 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ucleaire geneeskunde en radiologie
Enrollment
25
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ucleaire geneeskunde en radiologie

Eligibility Criteria

Inclusion Criteria

  • \- Inclusion criteria (Individuals with type 1 diabetes):
  • \* Within 6 months of diagnosis with type 1 diabetes
  • \* Auto\-antibody positive, \- Inclusion criteria (Control individuals):
  • \* No evidence of impaired glucose tolerance (HbA1c \< 42 mmol/mol (6%),
  • fasting glucose \< 6\.1 mmol/L), \- Inclusion criteria (general):
  • \* Age \> 18 years
  • Signed informed consent

Exclusion Criteria

  • \- Contra\-indication to MRI scanning, iron infusion or hypersensitivity to the
  • active substance or any of the excipients (like mentioned in the SPC).
  • \- Known drug allergies or history of severe asthma, eczema or other ectopic
  • \- Inability to lie still for at least 30 minutes or comply with imaging
  • \- Hemochromatosis or liver disease defined as ALAT or ASAT level of more than
  • three times the upper limit of normal range
  • \- Renal dysfunction defined as MDRD \< 40 ml/min/1\.73m^2
  • \- Current pregnancy or the wish to become pregnant within 2 months
  • \- Breast feeding
  • \- Incapability to provide informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials